Cite

HARVARD Citation

    Conte, C. et al. (n.d.). 2022-RA-820-ESGO The role of minimally invasive secondary cytoreduction in recurrent ovarian cancer patients. International journal of gynecological cancer. pp. A265-A266. [Online]. 
  
Back to record